New Cholesterol Pill Approved | Augusta Georgia News

FDA just approved Lipfendra, a new daily pill from Merck that slashes LDL cholesterol by up to 60%—a major leap for heart health. Unlike previous PCSK9 inhibitors that required injections, Lipfendra’s pill form offers convenience and could cost as little as $315 a month, slashing prices from $500–$600. It’s especially promising for high-risk patients who can’t tolerate statins or prefer not to inject. Early trials show no major side effects, though it must be taken on an empty stomach in the morning. Experts are calling this a game-changer for cholesterol management. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/a3d4b40f20c14cf2